3-O-acetylrubianol C (3AR-C) induces RIPK1-dependent programmed cell death by selective inhibition of IKKβ

Area of Science:

• Molecular Biology
• Cell Death Pathways
• Drug Discovery

Background:

• Tumor necrosis factor (TNF) signaling is crucial for regulating cell death, with receptor interacting protein kinase 1 (RIPK1) activation being a key checkpoint.
• Targeting RIPK1 offers potential therapeutic strategies to enhance TNF efficacy in cancer treatment.
• Understanding the molecular mechanisms controlling RIPK1 activity is essential for developing new anti-cancer agents.

Purpose of the Study:

• To investigate the effects of 3-O-acetylrubianol C (3AR-C), a triterpenoid from Rubia philippinesis, on TNF-induced cell death.
• To elucidate the molecular mechanism by which 3AR-C modulates TNF signaling and RIPK1 activity.
• To evaluate the potential of 3AR-C as a therapeutic agent for overcoming TNF resistance in cancer.

Main Methods:

• Treatment of mouse embryonic fibroblasts and human cancer cells with 3AR-C and TNF.
• Assessment of cell viability and cell death (apoptosis and necroptosis).
• Analysis of RIPK1 kinase activity, IKKα/β phosphorylation, TNF receptor complex formation, and c-FLIP_L expression.

Main Results:

• 3-O-acetylrubianol C (3AR-C) significantly promoted TNF-induced apoptotic and necroptotic cell death.
• 3AR-C upregulated RIPK1 kinase activity by selectively inhibiting IKKβ phosphorylation without affecting IKKα.
• 3AR-C sensitized cancer cells to TNF-induced death by facilitating TNFR1 complex-II and necrosome formation, particularly when c-FLIP_L was downregulated.

Conclusions:

• 3-O-acetylrubianol C (3AR-C) is a novel arborinane triterpenoid that acts as a potent activator of TNF-induced cell death.
• 3AR-C functions by inhibiting IKKβ phosphorylation, thereby promoting RIPK1 cytotoxic potential.
• 3AR-C represents a promising candidate for a selective IKKβ inhibitor to overcome TNF resistance in cancer therapy.